Travere Therapeutics (TVTX) EBIT (2011 - 2026)
Travere Therapeutics (TVTX) recorded EBIT of -$68.11 million in Q3 2026, compared with $24.93 million a year earlier.
Powered by 
Analysis
Travere Therapeutics (TVTX) EBIT (2011 - 2026) Analysis & Trends
On a TTM basis, Travere Therapeutics' EBIT came in at -$133.49 million as of Sep 30, 2026; for FY2025, it came in at -$62.82 million.
- Across earlier years, EBIT came in at -$323.83 million in FY2024, -$388.14 million in FY2023, -$319.81 million in FY2022 and -$199.43 million in FY2021.
- The Q3 2026 figure is the lowest quarterly EBIT since Q1 2024.
- Per Business Quant, the preceding three quarters came in at $3.95 million (Q2 2026), -$36.92 million (Q1 2026) and -$32.43 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Travere Therapeutics | 4.97 Bn | 4.56 Bn | 221.70 Mn | -68.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -68.11 Mn |
| Jun 30, 2026 | 3.95 Mn |
| Mar 31, 2026 | -36.92 Mn |
| Dec 31, 2025 | -32.43 Mn |
| Sep 30, 2025 | 24.93 Mn |
| Jun 30, 2025 | -12.65 Mn |
| Mar 31, 2025 | -42.67 Mn |
| Dec 31, 2024 | -60.74 Mn |
| Sep 30, 2024 | -56.15 Mn |
| Jun 30, 2024 | -67.70 Mn |
| Mar 31, 2024 | -139.24 Mn |
| Dec 31, 2023 | -94.23 Mn |
| Sep 30, 2023 | -92.59 Mn |
| Jun 30, 2023 | -103.95 Mn |
| Mar 31, 2023 | -97.37 Mn |
| Dec 31, 2022 | -86.70 Mn |
| Sep 30, 2022 | -82.60 Mn |
| Jun 30, 2022 | -78.53 Mn |
| Mar 31, 2022 | -71.98 Mn |
| Dec 31, 2021 | -84.85 Mn |
API Access
Travere Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();